These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17552035)

  • 1. Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.
    Cheng D; Xu WR; Liu CX
    World J Gastroenterol; 2007 May; 13(17):2496-503. PubMed ID: 17552035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects.
    Sharma PC; Jain A; Jain S
    Acta Pol Pharm; 2009; 66(6):587-604. PubMed ID: 20050522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of sparfloxacin in broiler chicken.
    Sriranjani D; Kalaiselvi L; Ramesh S; Mathuram LN; Sriram P
    Br Poult Sci; 2006 Dec; 47(6):720-5. PubMed ID: 17190680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of enrofloxacin after oral, intramuscular and bath administration in crucian carp (Carassius auratus gibelio).
    Shan Q; Fan J; Wang J; Zhu X; Yin Y; Zheng G
    J Vet Pharmacol Ther; 2018 Feb; 41(1):159-162. PubMed ID: 28603916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delafloxacin: First Global Approval.
    Markham A
    Drugs; 2017 Sep; 77(13):1481-1486. PubMed ID: 28748399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacodynamic and pharmacokinetic evaluation of respiratory fluoroquinolones. Guideline to selection of the most appropriate fluoroquinolone].
    Parra-Ruiz J; Hernández-Quero J
    Rev Esp Quimioter; 2012 Dec; 25(4):245-51. PubMed ID: 23303254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.
    Lee SJ; Awji EG; Park NH; Park SC
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of salting-out thin layer chromatography in computational prediction of minimum inhibitory concentration and blood-brain barrier penetration of some selected fluoroquinolones.
    Rageh AH; Atia NN; Abdel-Rahman HM
    J Pharm Biomed Anal; 2018 Sep; 159():363-373. PubMed ID: 30056224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of a Novel Anionic Fluoroquinolone-Delafloxacin.
    Tulkens PM; Van Bambeke F; Zinner SH
    Clin Infect Dis; 2019 Apr; 68(Suppl 3):S213-S222. PubMed ID: 30957164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue.
    Perletti G; Wagenlehner FM; Naber KG; Magri V
    Int J Antimicrob Agents; 2009 Mar; 33(3):206-10. PubMed ID: 19091519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHARMACOKINETICS OF A SINGLE DOSE OF ORAL AND SUBCUTANEOUS ENROFLOXACIN IN CARIBBEAN FLAMINGOS (PHOENICOPTERUS RUBER RUBER).
    Nau MR; Carpenter JW; KuKanich B; Warner M
    J Zoo Wildl Med; 2017 Mar; 48(1):72-79. PubMed ID: 28363047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Montoya L; Landoni MF
    Vet J; 2005 Sep; 170(2):222-9. PubMed ID: 16129342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of garenoxacin in elderly patients with respiratory tract infections.
    Ohsaki Y; Morita K; Takeda H; Kishino S; Okumura S; Fujiuchi S
    Int J Antimicrob Agents; 2010 Jun; 35(6):603-5. PubMed ID: 20207522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study.
    de Lucas JJ; Rodríguez C; Martella MB; Lábaque MC; Navarro JL; San Andrés MI
    Res Vet Sci; 2005 Jun; 78(3):265-7. PubMed ID: 15766947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How effective are ionization state-based QSPKR models at predicting pharmacokinetic parameters in humans?
    Gomatam A; Joseph B; Advani P; Shaikh M; Iyer K; Coutinho E
    Mol Divers; 2023 Aug; 27(4):1675-1687. PubMed ID: 36219381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Albert A; Delporte JP; Gustin P
    J Vet Pharmacol Ther; 2010 Apr; 33(2):183-8. PubMed ID: 20444043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of danofloxacin in common pheasants, guinea fowls and Japanese quails after intravenous and oral administration.
    Dimitrova DJ; Haritova AM; Dinev TD; Moutafchieva RG; Lashev LD
    Br Poult Sci; 2014 Feb; 55(1):120-5. PubMed ID: 24392829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.